TrialInvestigational new drugs2012
A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium.
Helen J Mackay et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this papertrialcites it